NO904149L - Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod. - Google Patents
Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod.Info
- Publication number
- NO904149L NO904149L NO90904149A NO904149A NO904149L NO 904149 L NO904149 L NO 904149L NO 90904149 A NO90904149 A NO 90904149A NO 904149 A NO904149 A NO 904149A NO 904149 L NO904149 L NO 904149L
- Authority
- NO
- Norway
- Prior art keywords
- aica riboside
- relationships
- blood
- procedure
- supply
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- External Artificial Organs (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Prostheses (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/301,222 US5082829A (en) | 1989-01-24 | 1989-01-24 | AICA riboside prodrugs |
US07/301,453 US5200525A (en) | 1989-01-24 | 1989-01-24 | Anti-seizure compounds |
US40810789A | 1989-09-15 | 1989-09-15 | |
PCT/US1990/000359 WO1990009163A2 (en) | 1989-01-24 | 1990-01-24 | Method and compounds for aica riboside delivery and for lowering blood glucose |
Publications (2)
Publication Number | Publication Date |
---|---|
NO904149D0 NO904149D0 (no) | 1990-09-24 |
NO904149L true NO904149L (no) | 1990-11-26 |
Family
ID=27404800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO90904149A NO904149L (no) | 1989-01-24 | 1990-09-24 | Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0427799B1 (no) |
JP (1) | JPH03504728A (no) |
KR (1) | KR910700057A (no) |
AT (1) | ATE114474T1 (no) |
AU (2) | AU5086190A (no) |
CA (1) | CA2008325A1 (no) |
DE (1) | DE69014562T2 (no) |
DK (1) | DK0427799T3 (no) |
FI (1) | FI904694A0 (no) |
IE (1) | IE75372B1 (no) |
IL (1) | IL93164A0 (no) |
NO (1) | NO904149L (no) |
WO (1) | WO1990009163A2 (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5214048A (en) * | 1987-05-19 | 1993-05-25 | Nippon Kayaku Kabushiki Kaisha | Oxetanocins |
US5736531A (en) | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
US5968914A (en) | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
US7776838B1 (en) | 1987-10-28 | 2010-08-17 | Wellstat Therapeutics Corporation | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
US5202459A (en) * | 1989-11-07 | 1993-04-13 | Nippon Kayaku Kabushiki Kaisha | Process for producing cyclobutane derivative |
JPH0615556B2 (ja) * | 1989-11-10 | 1994-03-02 | 旭化成工業株式会社 | 4―カルバモイル―1―β―D―リボフラノシル―イミダゾリウム―5―オレイト無水結晶 |
US5324730A (en) * | 1990-05-24 | 1994-06-28 | Nippon Kayaku Kabushiki Kaisha | Phenoxyphosphoryloxymethyl cyclobutyl purines |
IL99124A (en) * | 1990-08-10 | 1998-02-22 | Gensia Pharma | Substituted imidazole analogs of aica riboside |
US5236908A (en) * | 1991-06-07 | 1993-08-17 | Gensia Pharmaceuticals, Inc. | Methods of treating injury to the central nervous system |
IL103294A0 (en) * | 1991-09-30 | 1993-05-13 | Gensia Pharma | Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow |
IL108523A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain |
AU6452098A (en) | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel purine inhibitors of fructose-1,6-bisphosphatase |
JP2001515482A (ja) | 1997-03-07 | 2001-09-18 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−1,6−ビスホスファターゼの新規なベンズイミダゾールインヒビター |
EP1402895A1 (en) * | 1997-03-07 | 2004-03-31 | Metabasis Therapeutics, Inc. | Benzimidazole inhibitors of fructose 1,6-biphosphatase |
WO1998039342A1 (en) | 1997-03-07 | 1998-09-11 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
WO2000014095A1 (en) * | 1998-09-09 | 2000-03-16 | Metabasis Therapeutics, Inc. | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
AU2003242500B2 (en) * | 1998-09-09 | 2006-11-02 | Metabasis Therapeutics, Inc. | Novel Heteroaromatic Inhibitors of Fructose 1,6-bisphosphatase |
CN101125864A (zh) * | 1998-09-09 | 2008-02-20 | 症变治疗公司 | 新的果糖1,6-二磷酸酶的杂芳族抑制剂 |
US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
WO2000038666A2 (en) * | 1998-12-24 | 2000-07-06 | Metabasis Therapeutics, Inc. | A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
IL151248A0 (en) | 2000-03-08 | 2003-04-10 | Metabasis Therapeutics Inc | Novel aryl fructose-1,6-bisphosphatase inhibitors |
US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
PL365779A1 (en) * | 2000-07-06 | 2005-01-10 | Metabasis Therapeutics, Inc. | A combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes |
ES2192495B1 (es) | 2002-03-21 | 2005-02-16 | Universidad De Barcelona | Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina). |
EP1752450A1 (en) | 2005-08-01 | 2007-02-14 | Merck Sante | Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
WO2008086341A1 (en) * | 2007-01-09 | 2008-07-17 | Pericor Therapeutics, Inc. | Methods. compositions, and formulations for preventing or reducing adverse effects in a patient |
EP2058308A1 (fr) | 2007-11-12 | 2009-05-13 | Merck Sante | Dérivés de benzimidazoledihydrothiadiazinone comme inhibiteurs de fructose-1,6-biphosphatase et compositions pharmaceutiques les contenant. |
CA2739463C (en) * | 2008-10-03 | 2018-07-03 | Pericor Therapeutics, Inc. | Methods and compositions for treatment of acute heart failure |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1535561A (fr) * | 1966-06-18 | 1968-08-09 | Ajinomoto Kk | Méthode de préparation de l'adénine, de ses dérivés et intermédiaires |
US4575498A (en) * | 1983-07-21 | 1986-03-11 | Duke University | Method for restoring depleted purine nucleotide pools |
ATE135914T1 (de) * | 1986-03-27 | 1996-04-15 | Gensia Inc | Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung. |
US4912092A (en) * | 1986-03-27 | 1990-03-27 | The Regents Of The University Of California | Methods for increasing extracellular adenosine and for stabilizing mast cells |
-
1990
- 1990-01-24 IL IL93164A patent/IL93164A0/xx unknown
- 1990-01-24 AU AU50861/90A patent/AU5086190A/en not_active Abandoned
- 1990-01-24 IE IE27490A patent/IE75372B1/en not_active IP Right Cessation
- 1990-01-24 CA CA002008325A patent/CA2008325A1/en not_active Abandoned
- 1990-01-24 AT AT90903063T patent/ATE114474T1/de active
- 1990-01-24 DE DE69014562T patent/DE69014562T2/de not_active Expired - Fee Related
- 1990-01-24 JP JP2503252A patent/JPH03504728A/ja active Pending
- 1990-01-24 WO PCT/US1990/000359 patent/WO1990009163A2/en active IP Right Grant
- 1990-01-24 DK DK90903063.7T patent/DK0427799T3/da active
- 1990-01-24 EP EP90903063A patent/EP0427799B1/en not_active Expired - Lifetime
- 1990-09-24 NO NO90904149A patent/NO904149L/no unknown
- 1990-09-24 FI FI904694A patent/FI904694A0/fi not_active Application Discontinuation
- 1990-09-26 KR KR1019900702149A patent/KR910700057A/ko not_active Application Discontinuation
-
1993
- 1993-12-13 AU AU52360/93A patent/AU5236093A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1990009163A3 (en) | 1991-01-24 |
IE900274L (en) | 1990-07-24 |
DE69014562D1 (de) | 1995-01-12 |
DE69014562T2 (de) | 1995-06-22 |
KR910700057A (ko) | 1991-03-13 |
EP0427799A1 (en) | 1991-05-22 |
ATE114474T1 (de) | 1994-12-15 |
CA2008325A1 (en) | 1990-07-24 |
AU5236093A (en) | 1994-02-24 |
IL93164A0 (en) | 1990-11-05 |
NO904149D0 (no) | 1990-09-24 |
WO1990009163A2 (en) | 1990-08-23 |
JPH03504728A (ja) | 1991-10-17 |
FI904694A0 (fi) | 1990-09-24 |
IE75372B1 (en) | 1997-09-10 |
AU5086190A (en) | 1990-09-05 |
EP0427799B1 (en) | 1994-11-30 |
DK0427799T3 (da) | 1995-05-08 |
EP0427799A4 (en) | 1991-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO904149L (no) | Fremgangsmaate og forbindelser for tilfoersel av aica-ribosid for nedsettelse av glukosekonsentrasjonen i blod. | |
PL346520A1 (en) | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase | |
BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
MY124091A (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c | |
ES2087061T3 (es) | Utilizacion de ribosido o ribotido de aica para la fabricacion de un medicamento contra la crisis cardiaca o el infarto de miocardio en los pacientes que sufren de ateroesclerosis. | |
BG105079A (en) | Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance | |
HK1028957A1 (en) | Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain | |
MXPA02008722A (es) | Inhibidores novedosos de aril fructosa-1,6-bisfosfatasa. | |
ES2183952T3 (es) | Tratamiento de diabetes tipo ii con dosis elevadas de tripicolinato cromico. | |
NO882853L (no) | Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocyttfunkjon. | |
EP0354322A3 (en) | Antidiabetic alpha-substituted phosphonates | |
NL960024I1 (nl) | Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten. | |
EP0334361A3 (en) | Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives | |
GB2204415B (en) | Amperometric method for the quantitative determination of 1,4 dihydronicotinamide adenine dinucleotide (nadh) and its phosphorylated derivative in solution. | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
BR0001794A (pt) | Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares) | |
IT1116032B (it) | Composizione e procedimento per la determinazione della concentrazione del glucosio in fluidi corporei | |
IT8349080A0 (it) | Pigiama munito di aperture chiudibili per la ispezione corporea, in particolare per pazienti degenti | |
DE69738292D1 (de) | Nährungszusammensetzung für sport | |
ATE207357T1 (de) | Verwendung von cotinin zur linderung des tabakentzugssyndrom | |
DE59408344D1 (de) | Verwendung grenzwertig wirksamer Arzneiformen mit Betablockern | |
EP0311467A3 (en) | Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes | |
TH52878A3 (th) | ไธอิโนไพริมิดิน | |
KR890700352A (ko) | 히드라진 설페이트를 사용하여 암환자의 생존을 연장시키는 방법 | |
Malinovskaia et al. | The Holter monitoring of patients with newly occurring and progressing stenocardia |